An Affiliate Member in good standing may sponsor one abstract for each submission deadline provided that he or she is the presenter of the abstract. (Affiliate Members are not required to provide an endorser.) Permission to list an AACR member as a sponsor or endorser must be obtained prior ...
An Affiliate Member in good standing may sponsor one abstract for each submission deadline provided that he or she is the presenter of the abstract. (Affiliate Members are not required to provide an endorser.) Permission to list an AACR member as a sponsor or endorser must be obtained prior ...
2024年4月5日-10日,第115届AACR年会在美国圣地亚哥举行,来自全球各地的超过22,500位肿瘤科学家、医生及相关企业代表注册参会。 会议现场图片(来源:X平台) AACR Annual Meeting 2024在X社交平台上共有6,290位参与者,推送了26,313个帖子,产生超过5.53亿次阅读。The Innovation本年度主要由医学及肿瘤相关X平台账号参与...
Do late-breaking abstracts require a place-holder submission? No, a placeholder abstract for late-breaking abstracts is not required during the general Call for Abstracts. Late-breaking abstracts may be submitted starting September 1. Please note: only paradigm shifting basic science discovery, or tr...
Abstract Submissions Open :May 1, 2024 Abstract Submission Closes :July 10, 2024 at 11:59 PM, CT. Decision Letters and Presentation Instructions will be emailed to the Presenting Author : Late September/Early October 2024 Late-Breaking Abstract Submissions Open :September 1, 2024 ...
development across multiple tumor types, including FRα-high/mid/low ovarian cancers and other FRα-expressing indications, including non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer. An investigational new drug (IND) submission or foreign equivalent is planne...
development across multiple tumor types, including FRα-high/mid/low ovarian cancers and other FRα-expressing indications, including non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer. An investigational new drug (IND) submission or foreign equivalent is planne...
On February 20, 2024, it was announced that theAmerican Association for Cancer Research(AACR) will honor Chi Van Dang, MD, PhD, Fellow of the AACR Academy, with the 2024 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research during theAACR Annual Meeting 2024...
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected candidates from its oncology pipeline at the American Association for Cancer Research (“AACR”) Annual Meeting 2024 in San Diego, California, fro...